The FDA granted accelerated approval to the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis (RRP).

In nearly 443,000 US adults, both low-frequency and heavy cannabis use were linked to higher odds of cardiovascular disease, led by stroke.

New abstracts show the oral PCSK9 inhibitor cut LDL-C by 57% to 63% across PREVENT risk groups, with reductions maintained in an extension study.

Patients on tegoprubart reported fewer transplant-related symptoms and better quality of life at 12 months than those on ...

Facing steep 2027 cost increases, employers are narrowing obesity drug coverage, while direct-to-employer models let them cap ...